Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

lncRNAs are important for understanding and treating skin diseases.

Histone modification is key in treating chronic inflammatory skin diseases.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Severe alopecia areata may increase the risk of heart-related diseases.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

miR-155-5p can help diagnose and track alopecia areata severity.

People with Alopecia Areata often have lower zinc levels, and more hair loss is linked to even lower zinc levels.